7 insiders have filed at EDIT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| O'Neill Gilmore Neil | CEO | 263.7k | 0.269% | 9 sells $901k | |
| Mei Baisong | EVP, Chief Medical Officer | 133.4k | 0.136% | 6 sells $270k | |
| Lucera Erick | EVP, Chief Financial Officer | 112.7k | 0.115% | 2 sells $132k | |
| Eaton Bruce | EVP, Cbo And CTO | 74.8k | 0.076% | 6 sells $16k | |
| Burkly Linda | EVP, Chief Scientific Officer | 68.0k | 0.07% | 7 sells $88k | |
| Hopfield Jessica | Director | 67.7k | 0.069% | 1 buys $254k | |
| Parison Amy | SVP, Chief Financial Officer | 15.4k | 0.016% | 5 sells $6k |
Full register at boothcheck.com/insiders/EDIT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.